Hypertension artérielle pulmonaire disproportionnée : caractéristiques et pronostic d’une cohorte de patients niçois référés au laboratoire d’échocardiographie

Chaouat, 2008, Pulmonary hypertension in COPD, Eur Respir J, 32, 1371, 10.1183/09031936.00015608 Minai, 2010, Pulmonary hypertension in COPD: epidemiology, significance and management: pulmonary vascular disease: the global perspective, Chest, 137, 39S, 10.1378/chest.10-0087 Simonneau, 2009, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, 54, S43, 10.1016/j.jacc.2009.04.012 Scharf, 2002, Hemodynamic characterization of patients with severe emphysema, Am J Respir Crit Care Med, 166, 314, 10.1164/rccm.2107027 1963, Report of an expert committee, Circulation, 27, 594, 10.1161/01.CIR.27.4.594 Weitzenblum, 2003, Chronic core pulmonale, Heart, 89, 225, 10.1136/heart.89.2.225 Han, 2007, Pulmonary diseases and the heart, Circulation, 116, 2992, 10.1161/CIRCULATIONAHA.106.685206 Kessler, 2001, Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease, Am J Respir Crit Care Med, 164, 219, 10.1164/ajrccm.164.2.2006129 Weitzenblum, 1981, Pronostic value of pulmonary artery pressure in chronic obstructive pulmonary disease, Thorax, 36, 1604, 10.1136/thx.36.10.752 1980, Continuous or nocturnal oxygen therapy in hyoxemic chronic obstructive lung disease, Ann Intern Med, 93, 391, 10.7326/0003-4819-93-3-391 1981, Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet, 1, 681 Oswald-Mammosser, 1995, Prognostic factors in COPD patients receiving long term oxygen therapy. Importance of pulmonary artery pressure, Chest, 107, 1193, 10.1378/chest.107.5.1193 Chaouat, 2005, Severe pulmonary hypertension and chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, 189, 10.1164/rccm.200401-006OC Weitzenblum, 2005, Severe pulmonary hypertension in COPD. Is it a distinct disease?, Chest, 127, 1477, 10.1378/chest.127.5.1480 Thabut, 2005, Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation, Chest, 127, 1531, 10.1378/chest.127.5.1531 Farber, 2004, Pulmonary hypertension, N Engl J Med, 351, 1655, 10.1056/NEJMra035488 Fartoukh, 2000, Severe pulmonary hypertension in histiocytosis X, Am J Respir Crit Care Med, 161, 216, 10.1164/ajrccm.161.1.9807024 Nunes, 2006, Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis, Thorax, 61, 68, 10.1136/thx.2005.042838 Horr A, Helman D, Davies D, Nathan S. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical chacteristics. Eur Respir J 2005;25:783–88. Olschewski, 1999, Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis, Am J Respir Crit Care Med, 160, 600, 10.1164/ajrccm.160.2.9810008 Ghofrani, 2002, Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial, Lancet, 360, 895, 10.1016/S0140-6736(02)11024-5 Collard, 2007, Sildenafil improves walk distance in idiopathic pulmonary fibrosis, Chest, 131, 897, 10.1378/chest.06-2101 Ahmadi-Simab, 2006, Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease, Eur J Clin Invest, 36, 44, 10.1111/j.1365-2362.2006.01695.x Ishikawa, 2008, A case of severe pulmonary hypertension associated with COPD treated with epoprostenol, Nihon Kokyuki Gakkai Zasshi, 46, 660 King, 2008, BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 177, 75, 10.1164/rccm.200705-732OC Stolz, 2008, A randomised, controlled trial of bosentan in severe COPD, Eur Respir J, 32, 619, 10.1183/09031936.00011308 Blanco, 2010, Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension, Am J Respir Crit Care Med, 181, 270, 10.1164/rccm.200907-0988OC Rietema, 2008, Sildenafil treatment in COPD does not affect stroke volume or exercice capacity, Eur Respir J, 31, 759, 10.1183/09031936.00114207 Morpugo, 1989, The heart in pulmonary hypertension due to chronic lung disease Naeieje R, Huez S. Right ventricular function in pulmonary hypertension: physiological concepts. Eur Hear J Suppl 2007;(9 suppl.):H5–H9. Naeije, 2005, Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 2, 20, 10.1513/pats.200407-037MS Santos, 2002, Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD, Eur Respir J, 19, 632, 10.1183/09031936.02.00245902 Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predict survival in exacerbations of COPD. Chest 2008;134:263–72. Giaid, 1993, Expression of endothelin 1 in the lungs of patients with pulmonary hypertension, N Engl J Med, 328, 1732, 10.1056/NEJM199306173282402 Galié, 2004, The endothelin system in pulmonary arterial hypertension, Cardiovasc Res, 61, 227, 10.1016/j.cardiores.2003.11.026 Barton, 2008, Endothelin: 20 years from discovery to therapy, Can J Physiol Pharmacol, 86, 485, 10.1139/Y08-059 Dinh-Xuan, 1991, Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease, N Engl J Med, 324, 1539, 10.1056/NEJM199105303242203 Carratu, 2008, Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension, BMC Pulm Med, 8, 20, 10.1186/1471-2466-8-20 Eddahibi, 2003, Polymorphism of serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease, Circulation, 108, 1839, 10.1161/01.CIR.0000091409.53101.E8 Eddahibi, 2006, Interleukin-6 gene polymorphysm confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 3, 475, 10.1513/pats.200603-038MS Eddahibi, 2000, Attenued hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene, J Clin Invest, 105, 1555, 10.1172/JCI8678 Eddahibi, 2001, Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, J Clin Invest, 108, 1141, 10.1172/JCI200112805 Hoeper, 2008, Treating pulmonary hypertension in COPD: where do we start?, Eur Respir J, 32, 541, 10.1183/09031936.00091908